跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BERTA
首页
药物
BERTA
BERTA
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Oral Care Compositions
申请人: BERTA JAMES ALBERT
优先权: 2008
US
WO
2 件公开
COMPOSITION FOR USE IN THE PREVENTION OF DENTAL CARIES
申请人: LOGIDEX S R L
优先权: 2020
EP
Use Of 3-Substituted-2-(Diphenylmethy)-1-Azabicyclo[2.2.2]Octanes For Treating Mrg-X1 Receptor Mediated Diseases
申请人: KUNAPULI PRIYA
优先权: 2006
US
Oxazolyl-pyrazole derivatives as kinase inhibitors
申请人: BERTA DANIELA
优先权: 2002
US
Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery
申请人: SILVER DAVID M
优先权: 2003
US
Crystal forms of olanzapine and processes for their preparation
申请人: KOTAR JORDAN BERTA
优先权: 2002
US
TGF-BETA PATHWAY INHIBITORS FOR ENHANCEMENT OF CELLULAR REPROGRAMMING OF HUMAN CELLS
申请人: GRSKOVIC MARICA
优先权: 2010
US
Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders
申请人: TOEZSER JOZSEF
优先权: 2007
US
药物
反馈